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ABSTRACT 
Curcuma mangga is a medicinal plant, and its rhizomes are often used to treat various 
conditions, such as fever, thorax pain, itching, stomachaches, skin diseases, gout, and asthma. 
Although C. mangga is commonly used, information on the relationship between its chemical 
constituents and the bioactivities of the rhizomes is still limited. The extraction solvents used 
have a strong effect on the metabolite profile and the bioactivity of the extract. A nuclear 
magnetic resonance (NMR)-based metabolomics approach was used to differentiate the 
metabolite profiles of hexane, chloroform, ethyl acetate, and methanol fractions of C. mangga 
rhizomes and to correlate the metabolites with α-glucosidase inhibitory activity. Primary and 
secondary metabolites were identified, including curcuminoids, carbohydrates, terpenoids, and 
amino acids. The ultra-performance liquid chromatography–tandem mass spectrometry 
(UPLC–MS/MS) analysis of the most active fraction (ethyl acetate) revealed the identification 
of additional metabolites, such as zerumin A, epigallocatechin, p-hydroxycinnamic, and 
copallic acids. A partial least square (PLS) biplot demonstrated that the existence of curcumin, 
demethoxycurcumin, curcumanggoside, calcaratarin A, labda-8(17),12-diene-15,16-dial, 
zerumin B, and difurocumenonol in the ethyl acetate fraction could be responsible for the α-
glucosidase inhibitory activity. 
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